SPECTRAL MEDICAL
Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device … Read more
SPECTRAL MEDICAL (SD4) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, SPECTRAL MEDICAL (SD4) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
SPECTRAL MEDICAL - Net Assets Trend (None–None)
This chart illustrates how SPECTRAL MEDICAL's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for SPECTRAL MEDICAL (None–None)
The table below shows the annual net assets of SPECTRAL MEDICAL from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to SPECTRAL MEDICAL's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
SPECTRAL MEDICAL Competitors by Market Cap
The table below lists competitors of SPECTRAL MEDICAL ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SilverBox Corp IV
NYSE:SBXD-UN
|
$167.56 Million |
|
Hunan Lead Power Dazhi Technology Inc Co
SHE:300530
|
$167.60 Million |
|
W-SCOPE CHUNGJU PLANT LTD (PROPOSE
KQ:393890
|
$167.63 Million |
|
Ventec International Group Co Ltd
TW:6672
|
$167.65 Million |
|
P.T. Bank Pan Indonesia Tbk
F:PTQ
|
$167.53 Million |
|
Saniona AB
ST:SANION
|
$167.38 Million |
|
Shenzhen Bestek Technology Co Ltd
SHE:300822
|
$167.38 Million |
|
Tien Phong Securities Corp
VN:ORS
|
$167.38 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SPECTRAL MEDICAL's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares SPECTRAL MEDICAL's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently SPECTRAL MEDICAL utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares SPECTRAL MEDICAL's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $10,792,710,184
- Average return on equity (ROE) among peers: -33.38%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SPECTRAL MEDICAL (SD4) | €- | N/A | N/A | $167.55 Million |
| Spermosens AB (publ) (9R5) | $23.64 Million | -27.17% | 0.09x | $517.28K |
| BML Inc (BMZ) | $81.13 Billion | 8.19% | 0.43x | $462.01 Million |
| Genomic Vision Société Anonyme (G09) | $3.07 Million | -162.85% | 1.21x | $711.54K |
| ICON Public Limited Company (IJF) | $1.85 Billion | 17.96% | 0.86x | $6.43 Billion |
| Adicon Holdings Limited (K0U) | $1.77 Billion | 2.65% | 1.64x | $138.53 Million |
| WuXi XDC Cayman Inc. (L74) | $1.48 Billion | 10.52% | 0.69x | $2.11 Billion |
| NanoRepro AG (NN6) | $57.61 Million | 51.59% | 0.37x | $16.84 Million |
| PERRIGO (PGO) | $24.67 Million | -167.93% | 0.99x | $6.37K |